Forward Looking Statements



The following Management's Discussion and Analysis of Financial Condition and
Results of Operations should be read in conjunction with a review of the other
Items included in this Annual Report and our December 31, 2021 Consolidated
Financial Statements included elsewhere in this report. Certain statements
contained in this "Management's Discussion and Analysis of Financial Condition
and Results of Operations" may be deemed to be forward-looking statements. See
"Special Note Regarding Forward-Looking Statements."

Overview



We are a global provider of transaction processing solutions, enterprise
information management, document management and digital business process
services. Our technology-enabled solutions allow global organizations to address
critical challenges resulting from the massive amounts of data obtained and
created through their daily operations. Our solutions address the life cycle of
transaction processing and enterprise information management, from enabling
payment gateways and data exchanges across multiple systems, to matching inputs
against contracts and handling exceptions, to ultimately depositing payments and
distributing communications. We believe our process expertise, information
technology capabilities and operational insights enable our customers'
organizations to more efficiently and effectively execute transactions, make
decisions, drive revenue and profitability, and communicate critical information
to their employees, customers, partners, and vendors.

History



We are a former special purpose acquisition company that completed our initial
public offering on January 22, 2015. In July 2017, Exela Technologies, Inc.
("Exela"), formerly known as Quinpario Acquisition Corp. 2 ("Quinpario"),
completed its acquisition of SourceHOV Holdings, Inc. ("SourceHOV") and Novitex
Holdings, Inc. ("Novitex") pursuant to the business combination agreement dated
February 21, 2017 ("Novitex Business Combination"). In conjunction with the
completion of the Novitex Business Combination, Quinpario was renamed Exela
Technologies, Inc.

The Novitex Business Combination was accounted for as a reverse merger for which
SourceHOV was determined to be the accounting acquirer. Outstanding shares of
SourceHOV were converted into our Common Stock, presented as a recapitalization,
and the net assets of Quinpario were acquired at historical cost, with no
goodwill or other intangible assets recorded. The acquisition of Novitex was
treated as a business combination under ASC 805 and was accounted for using the
acquisition method. The strategic combination of SourceHOV and Novitex formed
Exela, which is one of the largest global providers of information processing
solutions based on revenues.

Sale of Non-core Assets

On March 16, 2020, the Company and its indirect wholly owned subsidiaries, Merco
Holdings, LLC and SourceHOV Tax, LLC entered into a Membership Interest Purchase
Agreement with Gainline Source Intermediate Holdings LLC at which time Gainline
Source Intermediate Holdings LLC acquired all of the outstanding membership
interests of SourceHov Tax, LLC for $40.0 million subject to adjustment as set
forth in the purchase agreement. On July 22, 2020, the Company completed the
sale of its physical records storage and logistics business for a purchase

price
of $12.3 million.

                                       43

  Table of Contents

Reverse Stock Split

On January 25, 2021, we effected a one-for-three reverse split of our issued and
outstanding shares of our Common Stock. At the effective time of the reverse
split, every three (3) shares of Common Stock issued and outstanding were
automatically combined into one (1) share of issued and outstanding Common
Stock, without any change in the par value per share. Our Common Stock began
trading on the Nasdaq on a Reverse Stock Split-adjusted basis on January 26,
2021. There was no change in our ticker symbol as a result of the Reverse Stock
Split.

Our Segments

Our three reportable segments are Information & Transaction Processing Solutions
("ITPS"), Healthcare Solutions ("HS"), and Legal & Loss Prevention Services
("LLPS"). These segments are comprised of significant strategic business units
that align our TPS and EIM products and services with how we manage our
business, approach our key markets and interact with our customers based on
their respective industries.

ITPS: Our largest segment, ITPS, provides a wide range of solutions and services
designed to aid businesses in information capture, processing, decisioning and
distribution to customers primarily in the financial services, commercial,
public sector and legal industries. Our major customers include many leading
banks, insurance companies, and utilities, as well as hundreds of federal, state
and government entities. Our ITPS offerings enable companies to increase
availability of working capital, reduce turnaround times for application
processes, increase regulatory compliance and enhance consumer engagement.

HS: HS operates and maintains a consulting and outsourcing business specializing
in both the healthcare provider and payer markets. We serve the top healthcare
insurance payers and hundreds of healthcare providers.

LLPS: Our LLPS segment provides a broad and active array of support services in connection with class action, bankruptcy labor, claims adjudication and employment and other legal matters. Our customer base consists of corporate counsel, government attorneys, and law firms.

Revenues



ITPS revenues are primarily generated from a transaction-based pricing model for
the various types of volumes processed, licensing and maintenance fees for
technology sales, and a mix of fixed management fee and transactional revenue
for document logistics and location services. HS revenues are primarily
generated from a transaction-based pricing model for the various types of
volumes processed for healthcare payers and providers. LLPS revenues are
primarily based on time and materials pricing as well as through transactional
services priced on a per item basis.

People

We draw on the business and technical expertise of our talented and diverse global workforce to provide our customers with high-quality services. Our business leaders bring a strong diversity of experience in our industry and a track record of successful performance and execution.



As of December 31, 2021, we had approximately 17,000 employees globally, with
54% located in Americas and EMEA, and the remainder located primarily in India,
the Philippines and China.

Costs associated with our employees represent the most significant expense for
our business. We incurred personnel costs of $542.6 million, $632.4 million and
$721.9 million for the years ended December 31, 2021, 2020 and 2019,
respectively. The majority of our personnel costs are variable and are incurred
only while we are providing our services.

                                       44

  Table of Contents

Facilities

We lease and own numerous facilities worldwide with larger concentrations of
space in Texas, Michigan, Connecticut, California, India, Mexico, the
Philippines, and China. Our owned and leased facilities house general offices,
sales offices, service locations, and production facilities.

The size of our active property portfolio as of December 31, 2021 was
approximately 3 million square feet, down by approximately 0.9 million square
feet compared to December 31, 2020. As of December 31, 2021, our active property
portfolio comprised of 122 leased properties and 8 owned properties. We reduced
our active portfolio of leased properties by 21 properties during 2021 with the
adoption of our work from anywhere program.

We believe that our current facilities are suitable and adequate for our current
businesses. Because of the interrelation of our business segments, each of the
segments uses substantially all of these properties at least in part.

Key Performance Indicators

We use a variety of operational and financial measures to assess our performance. Among the measures considered by our management are the following:



 ? Revenue by segment;


 ? EBITDA; and


 ? Adjusted EBITDA.


Revenue

We analyze our revenue by comparing actual monthly revenue to internal
projections and prior periods across our operating segments in order to assess
performance, identify potential areas for improvement, and determine whether
segments are meeting management's expectations.

EBITDA and Adjusted EBITDA



We view EBITDA and Adjusted EBITDA as important indicators of performance of our
consolidated operations. We define EBITDA as net income, plus taxes, interest
expense, and depreciation and amortization. We define Adjusted EBITDA as EBITDA
plus optimization and restructuring charges, including severance and retention
expenses; transaction and integration costs; other non-cash charges, including
non-cash compensation, (gain) or loss from sale or disposal of assets, and
impairment charges; and management fees and expenses. See "-Other Financial
Information (Non-GAAP Financial Measures)" for more information and a
reconciliation of EBITDA and Adjusted EBITDA to net loss, the most directly
comparable financial measure calculated and presented in accordance with GAAP.

                                       45

  Table of Contents

Results of Operations

Year Ended December 31, 2021, Compared to Year Ended December 31, 2020



                                                        Year Ended December 31,
                                                        2021                2020
Revenue:
ITPS                                               $      874,126      $    1,005,043
HS                                                        217,839             219,047
LLPS                                                       74,641              68,472
Total revenue                                           1,166,606           1,292,562
Cost of revenue (exclusive of depreciation and
amortization):
ITPS                                                      672,191             815,013
HS                                                        163,445             159,917
LLPS                                                       53,459              48,614
Total cost of revenues                                    889,095           1,023,544
Selling, general and administrative expenses
(exclusive of depreciation and amortization)              169,781          

186,104


Depreciation and amortization                              77,150          

   93,953
Related party expense                                       9,191               5,381
Operating profit (loss)                                    21,389            (16,420)
Interest expense, net                                     168,048             173,878
Debt modification and extinguishment costs (gain),
net                                                      (16,689)               9,589
Sundry expense (income), net                                  363               (153)
Other expense (income), net                                   401            (34,788)
Net loss before income taxes                            (130,734)           (164,946)
Income tax expense                                       (11,656)            (13,584)
Net loss                                           $    (142,390)      $    (178,530)


Revenue

For the year ended December 31, 2021, our revenue on a consolidated basis
decreased by $126.0 million, or 9.7%, to $1,166.6 million from $1,292.6 million
for the year ended December 31, 2020. We experienced revenue decline in our ITPS
segment and HS segment of $130.9 million and $1.2 million, respectively while
revenue increased in our LLPS segment by $6.2 million. Our ITPS, HS, and LLPS
segments constituted 74.9%, 18.7%, and 6.4% of total revenue, respectively, for
the year ended December 31, 2021, compared to 77.8%, 16.9%, and 5.3%,
respectively, for the year ended December 31, 2020. The revenue changes by
reporting segment were as follows:



ITPS-Revenue attributable to our ITPS segment was $874.1 million for the year
ended December 31, 2021 compared to $1,005.0 million for the year ended December
31, 2020. The revenue decline of $130.9 million, or 13.0%, is primarily
attributable to lower volumes and underutilization of resources as a result of
COVID-19 in addition to the impact of exiting contracts and statements of work
with certain customers that we believe was unpredictable, non-recurring and were
not a strategic fit to Company's long-term success or unlikely to achieve the
Company's long-term target margins ("transition revenue").

HS-For the year ended December 31, 2021, revenue attributable to our HS segment
decreased by $1.2 million, or 0.6%, to $217.8 million from $219.0 million for
the year ended December 31, 2020. The decrease in revenue was primarily driven
by lower transaction volumes from the impact of COVID-19 on our healthcare
customers.

LLPS-Revenue attributable to our LLPS segment was $74.6 million for the year
ended December 31, 2021 compared to $68.5 million for the year ended December
31, 2020. The increase in revenue by $6.2 million, or 9.0%, is primarily due to
an increase in legal claims administration services.



                                       46

  Table of Contents

Cost of Revenue

For the year ended December 31, 2021, our cost of revenue decreased by $134.4
million, or 13.1%, compared to the year ended December 31, 2020. In our ITPS and
HS segments, the decrease was primarily attributable to the corresponding
decline in revenues and operational efficiencies. Costs to our ITPS segment
decreased by $142.8 million, or 17.5% while costs related to our HS and LLPS
segments increased by $3.5 million, or 2.2% and $4.8 million, or 10.0%,
respectively.

The decrease in cost of revenues on a consolidated basis was primarily due to a
decrease in employee-related costs of $77.7 million, lower travel costs of $1.2
million, lower infrastructure and maintenance costs of $26.0 million and lower
pass through and other operating costs of $29.6 million which primarily include
supplies, cost of products, service expenses, postage and delivery. The lower
costs were attributable to cost and capacity management as a result of COVID-19
and transition revenue impact during the year ended December 31, 2021.

Cost of revenue for the year ended December 31, 2021 was 76.2% of revenue
compared to the 79.2% of revenue for the comparable same period in the prior
year. The decrease in cost of revenues, as a percentage of revenues by 3.0% was
primarily due to the impact of lower costs related to transition revenue that
continues to be gradually removed to further improve the gross margin profile of
the business.

Selling, General and Administrative Expenses



SG&A expenses decreased $16.3 million, or 8.8%, to $169.8 million for the year
ended December 31, 2021, compared to $186.1 million for the year ended December
31, 2020. The decrease was primarily attributable to lower employee related
costs by $15.5 million, lower travel costs of $0.5 million, lower legal and
professional fees of $2.0 million, lower infrastructure, maintenance and
operating costs of $6.3 million, offset by higher other costs of $7.9 million
that included a charge of $3.8 million for a settlement loss on our LLPS
segment. SG&A expenses increased as a percentage of revenues to 14.6% for the
year ended December 31, 2021 as compared to 14.4% for the year ended December
31, 2020.

Depreciation & Amortization

Total depreciation and amortization expense was $77.1 million and $94.0 million
for the years ended December 31, 2021 and 2020, respectively. The decrease in
total depreciation and amortization expense by $16.8 million was primarily due
to a reduction in depreciation expense as a result of the expiration of the
lives of assets acquired in prior periods and decrease in intangibles
amortization expense due to end of useful lives for certain intangible assets
during the year ended December 31, 2021 compared to the year ended December

31,
2020.

Related Party Expenses

Related party expense was $9.2 million for the year ended December 31, 2021
compared to $5.4 million for the year ended December 31, 2020. The increase in
expense is due to higher amount of fees payable to Rule 14, LLC under the master
service agreement for higher usage of services.

Interest Expense



Interest expense was $168.0 million for the year ended December 31, 2021
compared to $173.9 million for the year ended December 31, 2020. The decrease in
interest costs was partially attributable to lower interest on senior secured
term loan facility and other interest accruals incurred during the year ended
December 31, 2020.

Debt Modification and Extinguishment Costs (Gain), net

A net gain of $16.7 million for the year ended December 31, 2021 compared to a net loss of $9.6 million for the year ended December 31, 2020.



                                       47

Table of Contents


For the year ended December 31, 2021, the Company recorded a gain on early
extinguishment of debt of $30.6 million in connection with the repurchases of
senior secured term loans and secured 2023 notes. This gain was offset by $12.9
million in modification of debt under ASC 470-50 for the cost of exchange of
notes under the Public Exchange in December of 2021.

The Company recognized $1.3 million and $8.3 million in debt extinguishment
costs during 2020, for the partial debt extinguishment resulting from amendment
to the senior secured term loan in 2020 and the extinguishment of A/R Facility,
respectively.

Sundry Expense (Income), net

The increase in income by $0.5 million over the prior year period was primarily attributable to exchange rate fluctuations on foreign currency transactions.

Other Expense (Income), net



Other expense, net was $0.4 million for the year ended December 31, 2021
compared to other income of $34.8 million for the year ended December 31, 2020.
Other income for the year ended December 31, 2020 was primarily due to the
Company's divestment in SourceHOV Tax, LLC as part of our strategic plan to sell
non-core business assets as well as gains on the sale of physical records
storage and logistics business.

Income Tax Expense



We had an income tax expense of $11.7 million for the year ended December 31,
2021 compared to income tax expense of $13.6 million for the year ended December
31, 2020. The decrease in tax expense from the prior year was attributable to
the impact of the change in our judgment in 2021 related to the realizability of
deferred tax assets in certain state and foreign jurisdictions.

                                       48

  Table of Contents

Results of Operations

Year Ended December 31, 2020, Compared to Year Ended December 31, 2019



                                                       Year Ended December 31,
                                                        2020              2019
Revenue:
ITPS                                               $    1,005,043    $    1,234,284
HS                                                        219,047           256,721
LLPS                                                       68,472            71,332
Total revenue                                           1,292,562         1,562,337
Cost of revenue (exclusive of depreciation and
amortization):
ITPS                                                      815,013         1,001,655
HS                                                        159,917           180,045
LLPS                                                       48,614            43,035
Total cost of revenues                                  1,023,544         1,224,735
Selling, general and administrative expenses
(exclusive of depreciation and amortization)              186,104          

198,864


Depreciation and amortization                              93,953          

100,903


Impairment of goodwill and other intangible assets              -          

349,557
Related party expense                                       5,381             9,501
Operating profit (loss)                                  (16,420)         (321,223)
Interest expense, net                                     173,878           163,449
Debt modification and extinguishment costs (gain),
net                                                         9,589             1,404
Sundry expense (income), net                                (153)               969
Other expense (income), net                              (34,788)            14,429
Net loss before income taxes                            (164,946)         (501,474)
Income tax expense                                       (13,584)           (7,642)
Net loss                                           $    (178,530)    $    (509,116)


Revenue

For the year ended December 31, 2020, our revenue decreased by $269.8 million,
or 17.3%, to $1,292.6 million from $1,562.3 million for the year ended December
31, 2019. We experienced revenue declines in all of our segments primarily due
to lower transaction volumes since mid-March as a result of COVID-19. Our ITPS,
HS, and LLPS segments constituted 77.8%, 16.9%, and 5.3% of total revenue,
respectively, for the year ended December 31, 2020, compared to 79.0%, 16.4%,
and 4.6%, respectively, for the year ended December 31, 2019. The revenue
changes by reporting segment were as follows:



ITPS- For the year ended December 31, 2020, revenue attributable to our ITPS
segment decreased by $229.2 million, or 18.6% compared to the same period in the
prior year. The majority of this revenue decline is attributable to exiting
contracts and statements of work in late 2019 from certain customers with
revenue that we believe was unpredictable, non-recurring and were not a
strategic fit to Company's long-term success or unlikely to achieve the
Company's long-term target margins ("transition revenue") in addition to lower
transaction volumes since mid-March as a result of COVID-19.



HS- For the year ended December 31, 2020, revenue attributable to our HS segment
decreased by $37.7 million, or 14.7% compared to the same period in the prior
year primarily due to impact of COVID-19 on our healthcare customers.



LLPS- For the year ended December 31, 2020, revenue attributable to our LLPS
segment decreased by $2.9 million, or 4.0% compared to the same period in the
prior year primarily due to a decline in legal claims administration services.



                                       49

  Table of Contents

Cost of Revenue

For the year ended December 31, 2020, our direct costs decreased by $201.2 million, or 16.4%, compared to the year ended December 31, 2019. In our ITPS and HS segments, the decrease was primarily attributable to the corresponding decline in revenues. Costs on ITPS segment decreased by $186.6 million, or 18.6%, and HS segment decreased by $20.1 million, or 11.2%. Costs on LLPS segment increased by $5.6 million, or 13.0%.



The decrease in cost of revenues was primarily due to a decrease in
employee-related costs of $103.1 million, lower travel costs of $4.4 million,
lower infrastructure and maintenance costs of $17.6 million and other operating
costs of $29.5 million. The lower costs were attributable to cost and capacity
management as a result of COVID-19 and transition revenue impact during the year
ended December 31, 2020. Cost of revenue includes accelerated amortization of
$3.7 million for an operating lease right-of-use asset as the Company decided to
permanently close one of its production facilities.

Cost of revenue for the year ended December 31, 2020 was 79.2% compared to 78.4%
for the comparable same period in the prior year. The increase in cost of
revenues, as a percentage of revenues by 0.8% was primarily due to the impact of
costs related to the transition revenue that we expect to be gradually removed
to further improve the gross margin profile of the business.

Selling, General and Administrative Expenses



SG&A expenses decreased $12.7 million, or 6.4%, to $186.1 million for the year
ended December 31, 2020, compared to $198.9 million for the year ended December
31, 2019. The decrease was primarily attributable to lower employee related
costs by $13.0 million, lower travel costs of $4.0 million, lower infrastructure
and maintenance costs of $1.8 million and lower other costs of $4.3 million
offset by higher professional fees of $10.4 million.

SG&A expenses increased as a percentage of revenues to 14.4% in 2020 as compared
to 12.7% in 2019. The increase, as a percentage of revenues by 1.7%, was
primarily due to the decline in revenues brought on by the COVID-19 pandemic and
the transition revenue.

Depreciation & Amortization

Total depreciation and amortization expense was $94.0 million and $100.9 million
for the year ended December 31, 2020 and 2019, respectively. The decrease in
total depreciation and amortization expense by $7.0 million was primarily due to
a reduction in depreciation expense as a result of the expiration of the lives
of assets acquired in prior periods and decrease in intangibles amortization
expense due to end of useful lives for certain intangible assets during the year
ended December 31, 2020 compared to the year ended December 31, 2019.

Impairment of Goodwill and Other Intangible Assets

The Company recorded no impairment of goodwill and other intangible assets during the year 2020. Impairment of goodwill and other intangible assets for the year ended December 31, 2019 was $349.6 million.

Related Party Expenses


Related party expense was $5.4 million and $9.5 million for the year ended
December 31, 2020 and 2019, respectively. The lower related party expense in
2020 is attributable to lower reimbursements made to Ex-Sigma and Ex-Sigma 2. In
2019 the Company paid approximately $4.3 million in respect of legal expenses,
premium payments on the $55.8 million margin loan (obtained by Ex-Sigma 2 in
2017 to purchase additional common and preferred shares from the Company to help
meet the minimum cash requirements needed to close the Novitex Business
Combination) and other expenses related to secondary offerings that did not

recur in 2020.

                                       50

  Table of Contents

Interest Expense

Interest expense was $173.9 million and $163.4 million for the year ended
December 31, 2020 and 2019, respectively. The increase in interest costs was
partially attributable to the interest on securitization facilities and other
interest accruals that was not incurred during the corresponding period in 2019.

Debt Modification and Extinguishment Costs (Gain), net



Loss on extinguishment of debt for the years ended December 31, 2020 and 2019
was $9.6 million and $1.4 million respectively. The Company recognized $1.3
million and $8.3 million in debt extinguishment costs during 2020, for the
partial debt extinguishment resulting from amendment to the Term Loan in 2020
and the extinguishment of A/R Facility, respectively. The repricing and issuance
of the 2019 incremental Term Loans resulted in the partial debt extinguishment,
for which Exela recognized $1.4 million in debt extinguishment costs during
2019.

Sundry Expense (Income)

The decrease of $1.1 million over the prior year period was primarily attributable to foreign currency transaction gain / losses associated with exchange rate fluctuations.

Other Expense (Income)



Other expense (income), net was $(34.8) million and $14.4 million for the year
ended December 31, 2020 and 2019, respectively. The change was primarily due to
the $35.5 million resulting from gain recognized on the sale of SourceHOV Tax,
LLC and the $8.7 million gain on the sale of the physical records storage and
logistics business. Other expense (income) also includes an interest rate swap
entered into in 2017. The interest rate swap was not designated as a hedge. As
such, changes in the fair value of this derivative instrument are recorded
directly in earnings. For the year ended December 31, 2020, the fair value of
the interest swap liability decreased resulting in a gain of $0.4 million.

Income Tax Expense


We had an income tax expense of $13.6 million and $7.6 million for the year
ended December 31, 2020 and 2019, respectively. The change in the income tax
expense was primarily attributable to our change in judgment related to the
realizability of certain deferred tax assets. The change in the effective tax
rate for the year ended December 31, 2020, resulted from permanent tax
adjustments and valuation allowances, including valuation allowances against
disallowed interest expense deferred tax assets that are not
more-likely-than-not to be realized.

Other Financial Information (Non-GAAP Financial Measures)


We view EBITDA and Adjusted EBITDA as important indicators of performance. We
define EBITDA as net income, plus taxes, interest expense, and depreciation and
amortization. We define Adjusted EBITDA as EBITDA plus optimization and
restructuring charges, including severance and retention expenses; transaction
and integration costs; other non-cash charges, including non-cash compensation,
(gain) or loss from sale or disposal of assets, and impairment charges; and
management fees and expenses.

We present EBITDA and Adjusted EBITDA because we believe they provide useful
information regarding the factors and trends affecting our business in addition
to measures calculated under GAAP. Additionally, our credit agreement requires
us to comply with certain EBITDA related metrics. Refer to-"Liquidity and
Capital Resources-Indebtedness."

Note Regarding Non-GAAP Financial Measures



EBITDA and Adjusted EBITDA are not financial measures presented in accordance
with GAAP. We believe that the presentation of these non-GAAP financial measures
will provide useful information to investors in assessing our financial
performance and results of operations as our board of directors and management
use EBITDA and Adjusted

                                       51

  Table of Contents

EBITDA to assess our financial performance, because it allows them to compare
our operating performance on a consistent basis across periods by removing the
effects of our capital structure (such as varying levels of interest expense),
asset base (such as depreciation and amortization) and items outside the control
of our management team. Net loss is the GAAP measure most directly comparable to
EBITDA and Adjusted EBITDA. Our non-GAAP financial measures should not be
considered as alternatives to the most directly comparable GAAP financial
measure. Each of these non-GAAP financial measures has important limitations as
analytical tools because they exclude some but not all items that affect the
most directly comparable GAAP financial measures. These non-GAAP financial
measures are not required to be uniformly applied, are not audited and should
not be considered in isolation or as substitutes for results prepared in
accordance with GAAP. Because EBITDA and Adjusted EBITDA may be defined
differently by other companies in our industry, our definitions of these
non-GAAP financial measures may not be comparable to similarly titled measures
of other companies, thereby diminishing their utility.

The following tables present a reconciliation of EBITDA and Adjusted EBITDA to
our net loss, the most directly comparable GAAP measure, for the years ended
December 31, 2021, 2020, and 2019:

                                                            Year Ended December 31,
                                                       2021           2020           2019
Net Loss                                            $ (142,390)    $ (178,530)    $ (509,116)
Taxes                                                    11,656         13,584          7,642
Interest expense                                        168,048        173,878        163,449
Depreciation and amortization                            77,150         93,953        100,903
EBITDA                                                  114,464        102,885      (237,122)
Optimization and restructuring expenses (1)              22,246         45,616         73,936
Transaction and integration costs (2)                    15,872         16,620          5,703
Non-cash equity compensation (3)                          3,940          2,846          7,827
Other charges including non-cash (4)                     32,484         26,154         21,382
Loss/(Gain) on sale of assets (5)                       (2,779)            114            301
Loss/(Gain) on business disposals (6)                     1,296       (44,595)              -

Debt modification and extinguishment costs (gain), net

                                                    (16,689)          9,589          1,404
Loss/(Gain) on derivative instruments (7)                 (893)            375          4,337
Contract costs (8)                                        4,268          4,317         17,046
Dissenting shareholders expense (relating to the
Appraisal Action)                                             -              -         10,431
Litigation reserve                                        (925)          9,624              -
Impairment of goodwill and other intangible assets            -            

 -        349,557
Adjusted EBITDA                                         173,284        173,545        254,802

Adjustment represents net salary and benefits associated with positions,

current vendor expenses and existing lease contracts that are part of the (1) on-going savings and productivity improvement initiatives in process

transformation, customer transformation and post-merger or acquisition

integration.

(2) Represents costs incurred related to transactions for completed or

contemplated transactions during the period.

Represents the non-cash charges related to restricted stock units and options (3) that vested during the year at Ex-Sigma in the case of the SourceHOV 2013

Long Term Incentive Plan assumed by it in connection with the Novitex

Business Combination and the Company under the 2018 Stock Incentive Plan.

Represents fair value adjustments to deferred revenue and deferred rent (4) accounts established as part of purchase accounting and other non-cash

charges. Other charges include severance, retention bonus, facility

consolidation and other transition costs.

(5) Represents a loss/(gain) recognized on the disposal of property, plant, and

equipment and other assets.

(6) Represents a loss/(gain) recognized on the disposal of noncore-business


    assets.


                                       52

  Table of Contents

(7) Represents the impact of changes in the fair value of an interest rate swap

entered into during the fourth quarter of 2017.

(8) Represents costs incurred on new projects, contract start-up costs and

project ramp costs.

Liquidity and Capital Resources

Overview

At December 31, 2021, cash and cash equivalents totaled $48.1 million and we had no unutilized availability under our senior secured revolving credit facility.

We currently expect to spend approximately $15.0 to $20.0 million on total capital expenditures over the next twelve months. We will continue to evaluate additional capital expenditure needs that may arise due to changes in the business model due to COVID-19 and remote working.


As of December 31, 2021 and in comparison to December 31, 2020, the Company has
reduced debt by $338.5 million under previously announced initiatives. With an
objective to increase free cash flows and in order to maintain sufficient
liquidity to support profitable growth, the Company is pursuing further
reduction in debt and repricing of existing debt. The Company will continue to
pursue the sale of certain non-core businesses that are not central to the
Company's long-term strategic vision and invest in acquisition of businesses
that enhance the value proposition. There can be no assurances that any of these
initiatives will be consummated or will achieve its desired result.

On March 26, 2020, the Delaware Court of Chancery entered a judgment against one
of our subsidiaries in the amount of $57.7 million inclusive of costs and
interest arising out of the petition for appraisal pursuant to 8 Del. C. § 262
in the Delaware Court of Chancery, captioned Manichaean Capital, LLC, et al. v.
SourceHOV Holdings, Inc., C.A. No. 2017 0673 JRS (pursuant to which former
stockholders of SourceHOV sought, among other things, a determination of the
fair value of their 10,304 SourceHOV shares at the time of the Novitex Business
Combination) (the "Appraisal Action"). On December 31, 2021, we agreed to settle
the Appraisal Action along with a separate case brought by the same plaintiffs
for $63.4 million. Accordingly as of December 31, 2021, the Company accrued a
liability of $63.4 million for these matters, all of which is expected to be
paid during the first half of 2022 ($40 million having already been paid as of
March 16, 2022).

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act
("CARES Act") was enacted in response to the COVID-19 pandemic. The CARES Act,
among other things, includes provisions relating to refundable payroll tax
credits, deferment of employer side social security payments, net operating loss
carryback periods, alternative minimum tax credit refunds, modifications to the
net interest deduction limitations and technical corrections to tax depreciation
methods for qualified improvement property. The Company has implemented
favorable provisions of the CARES Act, including the refundable payroll tax
credits and the deferment of employer social security payments. At the end of
2021, the Company paid a portion of the deferred employer social security due as
per IRS guidance. The remaining balance of deferred employer social security
taxes will be paid by the end of fiscal 2022. The Company has utilized recently
enacted COVID-19 relief measures in various European jurisdictions, including
permitted deferrals of certain payroll, social security and value added taxes.
At the end of 2021, the Company paid a portion of these deferred payroll taxes,
social security and value added taxes. The remaining balance of deferred payroll
taxes, social security and value added taxes will be paid by the end of fiscal
2022 as per deferment timeline.

On December 17, 2020, certain subsidiaries of the Company entered into a $145.0
million securitization facility with a five year term (the "Securitization
Facility"). On December 17, 2020 the Company made the initial borrowing of
approximately $92.0 million under the Securitization Facility and used a portion
of the proceeds to repay previous securitization facility, which terminated on
such date. The Company used the remaining proceeds for general corporate
purposes.

On March 15, 2021, the Company, entered into a securities purchase agreement
with certain accredited institutional investors pursuant to which the Company
issued and sold to ten accredited institutional investors in a private

                                       53

Table of Contents



placement an aggregate of 9,731,819 unregistered shares of the Company's Common
Stock at a price of $2.75 per share and an equal number of warrants, generating
gross proceeds to the Company of $26.8 million. Cantor Fitzgerald acted as
underwriter in connection with such sale of unregistered securities and received
a placement fee of 5.5% of gross proceeds in connection with such service. In
selling the shares without registration, the Company relied on exemptions from
registration available under Section 4(a)(2) of the Securities Act of 1933 and
Rule 506 promulgated thereunder. Each private placement warrant entitles the
holder to purchase one share of Common Stock, will be exercisable at an exercise
price of $4.00 per share beginning on September 19, 2021 and will expire on
September 19, 2026.

On May 27, 2021, the Company entered into an At Market Issuance Sales Agreement
("First ATM Agreement") with B. Riley Securities, Inc. ("B. Riley") and Cantor
Fitzgerald & Co. ("Cantor"), as distribution agents under which the Company may
offer and sell shares of the Company's Common Stock from time to time through
the Distribution Agents, acting as sales agent or principal. On September 30,
2021, the Company entered into a second At Market Issuance Sales Agreement with
B. Riley, BNP Paribas Securities Corp., Cantor, Mizuho Securities USA LLC and
Needham & Company, LLC, as distribution agents (together with the First ATM
Agreement, the "ATM Agreement").

Sales of the shares of Common Stock under the ATM Agreement, will be in "at the
market offerings" as defined in Rule 415 under the Securities Act, including,
without limitation, sales made directly on or through the Nasdaq or on any other
existing trading market for the Common Stock, as applicable, or to or through a
market maker or any other method permitted by law, including, without
limitation, negotiated transactions and block trades. Shares of Common Stock
sold under the ATM Agreement are offered pursuant to the Company's Registration
Statement on Form S-3 (File No. 333-255707), filed with the SEC on May 3, 2021,
and declared effective on May 12, 2021 (the "2021 Registration Statement"), and
the prospectus dated May 12, 2021 included in the 2021 Registration Statement
and the related prospectus supplements for sales of shares of Common Stock

as
follows:

                                                     Weighted
                                          Number of  Average
                                          Shares     Price Per   Gross    Net
Supplement                  Period        Sold       Share       Proceeds Proceeds

Prospectus supplement dated May 28, 2021 49,423,706 $2.008 $99.3 $95.7 May 27, 2021 with an and through

                          million  

million


aggregate offering price of July 1, 2021
up to $100 million ("Common
ATM Program-1")
Prospectus supplement dated June 30, 2021 57,580,463 $2.603      $149.9   $144.4
June 30, 2021 with an       and through                          million  

million


aggregate offering price of September 2,
up to $150 million ("Common 2021
ATM Program-2")
Prospectus supplement dated October 6,    98,594,447 $1.327      $130.8   $126.4
September 30, 2021 with an  2021 through                         million  

million


aggregate offering price of December 31,
up to $250.0 million        2021
("Common ATM Program-3")


Cash Flows

The following table summarizes our cash flows for the periods indicated:



                                                             Year Ended 

December 31,


                                                        2021           2020 

2019


Net cash used in operating activities                $ (111,534)    $ (29,781)    $  (63,851)
Net cash provided by (used in) investing activities      (9,261)        21,438       (25,182)
Net cash provided by financing activities                 98,651        63,362         59,139
Subtotal                                                (22,144)        55,019       (29,894)
Effect of exchange rates on cash                           (105)         1,191            139

Net increase (decrease) in cash and cash equivalents (22,249) 56,210 (29,755)




                                       54

  Table of Contents

Analysis of Cash Flow Changes between the years ended December 31, 2021, December 31, 2020, and December 31, 2019



Operating Activities- Net cash used in operating activities was $111.5 million
for the year ended December 31, 2021, compared to cash used in operating
activities of $29.8 million for the year ended December 31, 2020. The increase
of $81.7 million in cash used in operating activities for the year ended
December 31, 2021 was due to lower cash flow from accounts receivable and lower
cash flows from accounts payable and accrued liabilities.

Net cash used in operating activities was $29.8 million for the year ended
December 31, 2020, compared to cash used in operating activities of $63.8
million for the year ended December 31, 2019. The increase of $34.0 million in
cash flows from operating activities for the year ended December 31, 2020 was
due to lower Gross profits in the corresponding period offset by higher cash
flow from working capital primarily driven by $46 million improvement in our
accounts receivables. "Gross profit" is defined as revenue less cost of revenue
(exclusive of depreciation and amortization). This decrease in cash flow was
significantly offset by higher cash flows from accounts receivables.

Investing Activities- Net cash used in investing activities was $9.2 million for
the year ended December 31, 2021, compared to cash provided by investing
activities of $21.4 million for the year ended December 31, 2020. The increase
of $30.6 million in cash used in investing activities for the year ended
December 31, 2021 was primarily due to $50.1 million total cash proceeds
received from asset sales in 2020, higher additions to Property, plant and
equipment and development of internal software, offset by $12.5 million used in
partial settlement of the liabilities related to the healthcare acquisition
announced early in the first quarter of 2019.

Net cash provided by investing activities was $21.4 million for the year ended
December 31, 2020, compared to cash used in investing activities of $25.2
million for the year ended December 31, 2019. The increase of $46.6 million in
cash used in investing activities for the year ended December 31, 2020 was
primarily due to $50.1 million total cash proceeds received from asset sales,
lower additions to Property, plant and equipment and development of internal
software offset by partial settlement of the liabilities related to the
healthcare acquisition announced early in the first quarter of 2019.

Financing Activities- Net cash provided by financing activities was $98.7
million for the year ended December 31, 2021, compared to cash provided by
financing activities of $63.4 million for the year ended December 31, 2020. The
increase of $35.3 million in cash provided by financing activities for the year
ended December 31, 2021 was primarily result of $391.6 million of net proceeds
from equity offerings offset by debt repurchases and repayments of our term
loans and senior notes of $380.5 million.

Net cash provided by financing activities was $63.4 million for the year ended
December 31, 2020, compared to cash provided by financing activities of $59.1
million for the year ended December 31, 2019. The increase of $4.3 million in
cash provided by financing activities for the year ended December 31, 2020 was
primarily due to the proceeds from securitization facilities and revolving
credit facility offset by principal payments made on debt.

Indebtedness



In connection with the Novitex Business Combination, we acquired debt facilities
and issued notes totaling $1.4 billion. Proceeds from the indebtedness were used
to pay off credit facilities existing immediately before the Novitex Business
Combination.

Senior Credit Facilities

On July 12, 2017, subsidiaries of the Company entered into a First Lien Credit
Agreement with Royal Bank of Canada, Credit Suisse AG, Cayman Islands Branch,
Natixis, New York Branch and KKR Corporate Lending LLC (the "Credit Agreement")
providing Exela Intermediate LLC, a wholly owned subsidiary of the Company, upon
the terms and subject to the conditions set forth in the Credit Agreement, (i) a
$350.0 million senior secured term loan maturing July 12, 2023 with an original
issue discount of $7.0 million, and (ii) a $100.0 million senior secured
revolving facility maturing July 12, 2022 (the "Revolving Credit Facility").

                                       55

  Table of Contents

On July 13, 2018, we were able to refinance the $343.4 million of term loans
then outstanding under the Credit Agreement (the "Repricing Term Loans") and
borrowed an additional $30.0 million pursuant to incremental term loans (the
"2018 Incremental Term Loans"). The proceeds of the 2018 Incremental Term Loans
were used by the Company for general corporate purposes and to pay related fees
and expenses.

On April 16, 2019, subsidiaries of the Company borrowed a further $30.0 million
pursuant to incremental term loans (the "2019 Incremental Term Loans", and,
together with the 2018 Incremental Terms Loans and Repricing Term Loans, the
"Term Loans"). The proceeds of the 2019 Incremental Term Loans were used to
replace cash spent for acquisitions, pay related fees, expenses and related
borrowings for general corporate purposes.

The Term Loans bear interest at a rate per annum of, at the borrower's option,
either (a) a LIBOR rate determined by reference to the costs of funds for
Eurodollar deposits for the interest period relevant to such borrowing, adjusted
for certain additional costs, subject to a 1.0% floor, or (b) a base rate
determined by reference to the highest of (i) the federal funds rate plus 0.5%,
(ii) the prime rate and (iii) the one-month adjusted LIBOR plus 1.0%, in each
case plus an applicable margin of 6.5% for LIBOR loans and 5.5% for base rate
loans. The Term Loans will mature on July 12, 2023. As of December 31, 2021, the
interest rate applicable for the first lien senior secured term loan was 7.5%.

The Term Loans are jointly and severally, irrevocably and unconditionally guaranteed by the nearly all of Company's U.S. subsidiaries, as a primary obligors and not merely as a sureties.



The borrower may voluntarily repay the Term Loans at any time, without
prepayment premium or penalty, subject to customary "breakage" costs with
respect to LIBOR rate loans. Other than as described above, the terms,
conditions and covenants applicable to the Incremental Term Loans are consistent
with the terms, conditions and covenants that were applicable to the Repricing
Term Loans under the Credit Agreement.

On May 18, 2020, we amended the Credit Agreement to, among other things, extend
the time for delivery of its audited financial statements for the year ended
December 31, 2019 and its financial statements for the quarter ended March 31,
2020. Pursuant to the amendment, we also agreed to amend the Credit Agreement
to, among other things: restrict the borrower and its subsidiaries' ability to
designate or invest in unrestricted subsidiaries; incur certain debt; create
certain liens; make certain investments; pay certain dividends or other
distributions on account of its equity interests; make certain asset sales or
other dispositions (or utilize the proceeds of certain asset sales to reinvest
in the business); or enter into certain affiliate transactions pursuant to the
negative covenants under the Credit Agreement. In addition, pursuant to the
amendment, the borrower under the Credit Agreement was required to maintain
minimum Liquidity (as defined in the amendment) of $35.0 million.

On December 9, 2021, in a separate transaction referred to as "Private Exchange"
(outside of the Public Exchange as discussed below), we agreed with three (3) of
its term loan lenders for partial repayment and partial exchange of their
outstanding balance of senior secured term loan under Credit Agreement for the
new 2026 Notes. The Company agreed with these participating lenders to repay
outstanding balance of $212.1 million of senior secured term loan under Credit
Agreement payable to them in cash consideration of $84.3 million and in new 2026
Notes of $127.8 million. In connection with the Private Exchange transaction,
the exchanging lenders provided consents to amend the Credit Agreement to (i)
eliminate all affirmative covenants, (ii) eliminate all negative covenants and
(iii) eliminate certain events of default (other than events of default relating
to payment obligations).

As a result of the Private Exchange, repurchases (as discussed below) and periodic principal repayments, $93.2 million aggregate principal amount of the senior secured term loan remains outstanding as of December 31, 2021.

Revolving Credit Facility; Letters of Credit



As of December 31, 2021 and December 31, 2020, our $100 million Revolving Credit
Facility was fully drawn taking into account letters of credit issued
thereunder. As of December 31, 2021 and December 31, 2020, we had outstanding
irrevocable letters of credit totaling approximately $0.5 million and $19.5
million, respectively, under the Revolving Credit Facility.

                                       56

  Table of Contents

Senior Secured 2023 Notes

Upon the closing of the Novitex Business Combination on July 12, 2017,
subsidiaries of the Company issued $1.0 billion in aggregate principal amount of
10.0% First Priority Senior Secured Notes due 2023 (the "2023 Notes"). The 2023
Notes bear interest at a rate of 10.0% per year. We pay interest on the 2023
Notes on January 15 and July 15 of each year, commencing on January 15, 2018.
The 2023 Notes are jointly and severally, irrevocably and unconditionally
guaranteed by the nearly all of Company's U.S. subsidiaries, on a senior basis,
as a primary obligors and not merely as a sureties. The 2023 Notes will mature
on July 15, 2023.

On October 27, 2021, we launched an offer to exchange (the "Public Exchange") up
to $225.0 million in cash and new 11.500% First-Priority Senior Secured Notes
due 2026 (the "2026 Notes") issued by subsidiaries of the Company's for the
outstanding 2023 Notes. The Public Exchange was for $900 in cash per $1,000
principal amount of 2023 Notes tendered subject to proration. The maximum amount
of cash to be paid was $225.0 million and the offer was not subject to any
minimum participation condition. In case of oversubscription to the cash offer,
tendered 2023 Notes would be accepted for cash on a pro rata basis (as a single
class). The balance of any tendered 2023 Notes not accepted for cash would be
exchanged into 2026 Notes on the basis of $1,000 principal amount of new 2026
Notes for each $1,000 principal amount of outstanding 2023 Notes tendered.

As of the expiration time of the Public Exchange, $912,660,000 aggregate
principal amount, or approximately 91.3%, of the 2023 Notes were validly
tendered pursuant to the Public Exchange. On December 9, 2021, upon the
settlement of the Public Exchange, $662,660,000 aggregate principal amount of
the 2026 Notes were issued and an aggregate $225.0 million in cash (plus accrued
but unpaid interest) was paid to participating holders in respect of the validly
tendered 2023 Notes.

As a result of the Public Exchange and repurchases (as discussed below), $22.8
million aggregate principal amount of the 2023 Notes remains outstanding as of
December 31, 2021.

In conjunction with the Public Exchange, we also solicited consents to amend
certain provisions in the indenture governing the 2023 Notes ("Notes
Amendments"). On December 1, 2021, on receipt of the requisite consents to the
Notes Amendments, the Company, and Wilmington Trust, National Association, as
trustee (the "2023 Notes Trustee"), entered into a third supplemental indenture
(the "Third Supplemental Indenture") to the indenture, dated as of July 12, 2017
(as amended and supplemented by (i) the first supplemental indenture, dated as
of July 12, 2017 and (ii) the second supplemental indenture, dated as of May 20,
2020, the "2023 Notes Indenture") governing the outstanding 2023 Notes. The
Third Supplemental Indenture amends the 2023 Notes Indenture and the 2023 Notes
to eliminate substantially all of the restrictive covenants, eliminate certain
events of default, modify covenants regarding mergers and consolidations and
modify or eliminate certain other provisions, including certain provisions
relating to future guarantors and defeasance, contained in the 2023 Notes
Indenture and the 2023 Notes. In addition, all of the collateral securing the
2023 Notes was released pursuant to the Third Supplemental Indenture.

Senior Secured 2026 Notes



On December 9, 2021, subsidiaries of the Company issued $790.5 million in
aggregate principal amount of 2026 Notes under the Public Exchange and Private
Exchange transactions discussed above. Apart from this, during December 2021 the
Company issued and sold $4.5 million in aggregate principal amount of 2026 Notes
generating net proceeds of $3.6 million. The 2026 Notes are guaranteed by
certain subsidiaries of the Company. The 2026 Notes bear interest at a rate of
11.5% per year. We will pay interest on the 2026 Notes on January 15 and July 15
of each year, commencing on July 15, 2022. The 2026 Notes will mature on July
12, 2026. As of December 31, 2021, we were in compliance with all covenants
required under the 2026 Notes.

On or after December 1, 2022, we may redeem the 2026 Notes in whole or in part
from time to time, at a redemption price of 100%, plus accrued and unpaid
interest, if any, to, but excluding, the applicable redemption date. In
addition, prior to December 1, 2022, we may redeem the 2026 Notes in whole or in
part from time to time, at a redemption price equal to 100% of the principal
amount of the 2026 Notes redeemed, plus the Applicable Premium as of, and
accrued and unpaid interest, if any, to, but excluding, the applicable
redemption date. "Applicable Premium"

                                       57

Table of Contents


means, with respect to any 2026 Note on any applicable redemption date, as
determined by us, the greater of: (1) 1% of the then outstanding principal
amount of the 2026 Note; and (2) the excess of: (a) the present value at such
redemption date of (i) the redemption price of the 2026 Note, at December 1,
2022 plus (ii) all required interest payments due on the 2026 Note through
December 1, 2022 (excluding accrued but unpaid interest), computed using a
discount rate equal to the treasury rate as of such redemption date plus 50
basis points; over (b) the then outstanding principal amount of the 2026 Note.

Repurchases



In July 2021 we commenced a debt buyback program to repurchase 2023 Notes and
senior secured term loans under the Credit Agreement, which is ongoing. During
the year ended December 31, 2021, we repurchased $64.5 million of the
outstanding principal amount of our 2023 Notes for a net cash consideration of
$48.4 million. The gain on early extinguishment of debt for the 2023 Notes
during the year ended December 31, 2021 totaled $15.3 million and is inclusive
of $0.6 million and $0.2 million write off of original issue discount and debt
issuance costs, respectively. During the year ended December 31, 2021, we also
repurchased $40.0 million of the outstanding principal amount of our senior
secured term loans under the Credit Agreement for a net cash consideration of
$22.8 million. The gain on early extinguishment of debt for the senior secured
term loan during the year ended December 31, 2021 totaled $15.3 million and is
inclusive of $0.4 million and $1.5 million write off of original issue discount
and debt issuance costs, respectively.

BRCC Facility



On November 17, 2021, GP2 XCV, LLC, a subsidiary of the Company ("GP2 XCV"),
entered into a borrowing facility with B. Riley Commercial Capital, LLC pursuant
to which the Company was able to borrow an original principal amount of $75.0
million, which was later increased to $115.0 million as of December 7, 2021 (as
the same may be amended from time to time, the "BRCC Facility"). The BRCC
Facility is secured by a lien on all the assets of GP2 XCV and by a pledge of
the equity of GP2 XCV. GP2 XCV is a bankruptcy-remote entity and as such its
assets are not available to other creditors of the Company or any of its
subsidiaries other than GP2 XCV. The facility will mature on March 31, 2023.
Interest under the BRCC Facility accrues at a rate of 11.5% per annum and is
payable quarterly on the last business day of each March, June, September and
December. The purpose of this facility was to fund certain repurchases of senior
secured term loan under the Credit Agreement and to provide funding of Public
Exchange transaction and Private Exchange transaction as discussed above. As of
December 31, 2021, there were borrowings of $115.0 million outstanding under the
BRCC Facility.

Securitization Facilities

On December 17, 2020, certain subsidiaries of Company closed on Securitization
Facility with a five year term. The Securitization Facility provided for an
initial funding of approximately $92.0 million supported by the receivables
portion of the borrowing base and, subject to contribution, a further funding of
approximately $53.0 million supported by inventory and intellectual property. On
December 17, 2020 we made the initial borrowing of approximately $92.0 million
under the Securitization Facility and used a portion of the proceeds to repay a
previous securitization facility and used the remaining proceeds for general
corporate purposes.

The initial documentation for the Securitization Facility includes (i) a Loan
and Security Agreement (the "Securitization Loan Agreement"), dated as of
December 10, 2020, by and among Exela Receivables 3, LLC (the "Securitization
Borrower"), a wholly-owned indirect subsidiary of the Company, the lenders
(each, a "Securitization Lender" and collectively the "Securitization Lenders"),
Alter Domus (US), LLC, as administrative agent (the "Securitization
Administrative Agent") and the Company, as initial servicer, pursuant to which
the Securitization Lenders will make loans to the Securitization Borrower to be
used to purchase receivables and related assets from the Securitization Parent
SPE (as defined below), (ii) a First Tier Receivables Purchase and Sale
Agreement (the, dated as of December 17, 2020, by and among Exela Receivables 3
Holdco, LLC (the "Securitization Parent SPE"), a wholly-owned indirect
subsidiary of the Company, and certain other indirect, wholly-owned subsidiaries
of the Company listed therein (collectively, the "Securitization Originators"),
and the Company, as initial servicer, pursuant to which each Securitization
Originator has sold or contributed and will sell or contribute to the
Securitization Parent SPE certain receivables and related assets in
consideration for a combination of cash and equity in the Securitization Parent
SPE, (iii)

                                       58

  Table of Contents

a Second Tier Receivables Purchase and Sale Agreement, dated as of December 17,
2020, by and among, the Securitization Borrower, the Securitization Parent SPE
and the Company, as initial servicer, pursuant to which Securitization Parent
SPE has sold or contributed and will sell or contribute to the Securitization
Borrower certain receivables and related assets in consideration for a
combination of cash and equity in the Securitization Borrower, (iv) the
Sub-Servicing Agreement, dated as of December 17, 2020, by and among the Company
and each Securitization Originator, (v) the Pledge and Guaranty, dated as of the
December 10, 2020, between the Securitization Parent SPE and the Administrative
Agent, and (vi) the Performance Guaranty, dated as of December 17, 2020, between
the Company, as performance guarantor, and the Securitization Administrative
Agent (and together with all other certificates, instruments, UCC financing
statements, reports, notices, agreements and documents executed or delivered in
connection with the Securitization Loan Agreement, the "Securitization
Agreements"). On April 11, 2021, the Company amended the Securitization Loan
Agreement and agreed to, among other things, extend the option to contribute
inventory and intellectual property to the borrowing base from April 10, 2021 to
September 30, 2021 (which did not occur).

The Securitization Borrower, the Company, the Securitization Parent SPE and the
Securitization Originators provide customary representations and covenants under
the Securitization Agreements. The Securitization Loan Agreement provides for
certain events of default upon the occurrence of which the Securitization
Administrative Agent may declare the facility's termination date to have
occurred and declare the outstanding Securitization Loan and all other
obligations of the Securitization Borrower to be immediately due and payable,
however the Securitization Facility does not include an ongoing liquidity
covenant like the A/R Facility and aligns reporting obligations with the
Company's other material indebtedness agreements.

The Securitization Borrower and Securitization Parent SPE were formed in
December 2020, and are consolidated into the Company's financial statements. The
Securitization Borrower and Securitization Parent SPE are bankruptcy remote
entities and as such their assets are not available to creditors of the Company
or any of its subsidiaries. Each loan under the Securitization Facility bears
interest on the unpaid principal amount as follows: (i) if a Base Rate Loan, at
a rate per annum equal to (x) the greatest of (a) the Prime Rate in effect on
such day, (b) the Federal Funds Effective Rate in effect on such day plus 0.50%
and (c) the Adjusted LIBOR Rate (as defined in the Securitization Loan
Agreement) plus 1.00%, plus (y) 8.75%; or (ii) if a LIBOR Rate Loan, at the
Adjusted LIBOR Rate plus 9.75%. As of December 31, 2021, there were borrowings
of $91.9 million outstanding under the Securitization Facility.

Selected Financial Information



The following selected consolidated financial data should be read in conjunction
with Item 8, "Financial Statements and Supplementary Data" of this Annual Report
in order to fully understand factors that may affect the comparability of the
financial data. The following selected Consolidated Balance Sheet data as of
December 31, 2021 and 2020 and selected Consolidated Statements of Operations
for the years ended December 31, 2021, 2020 and 2019 are derived from our
audited financial statements included in Item 8 of this Annual Report. The
following selected consolidated financial data is provided here as historical
trend information. The historical results do not necessarily indicate results
expected for any future period.



                                                         Year Ended December 31,
(in thousands, except share
and per share data)                  2021           2020           2019          2018           2017
Statements of Operations
Information:
Revenue                           $ 1,166,606    $ 1,292,562    $ 1,562,337   $ 1,586,222    $ 1,145,891
Cost of revenue (exclusive of
depreciation and amortization)        889,095      1,023,544      1,224,735     1,213,403        827,544
Selling, general and
administrative expenses
(exclusive of depreciation and
amortization)                         169,781        186,104        198,864       184,908        220,955
Depreciation and amortization          77,150         93,953        100,903       138,077         98,890
Impairment of goodwill and
other intangible assets                     -              -        349,557        48,127         69,437
Related party expense                   9,191          5,381          9,501        12,403         33,431
Operating (loss) income                21,389       (16,420)      (321,223)      (10,696)      (104,366)
Other expense (income), net:
Interest expense, net                 168,048        173,878        163,449       155,991        129,676
Debt modification and
extinguishment costs (gain)          (16,689)          9,589          1,404

        1,067         35,512


                                       59

  Table of Contents

Sundry expense (income), net               363          (153)            969        (3,271)          2,295
Other expense (income), net                401       (34,788)         14,429        (3,030)        (1,297)
Net loss before income taxes         (130,734)      (164,946)      (501,474)      (161,453)      (270,552)
Income tax (expense) benefit          (11,656)       (13,584)        (7,642)        (8,353)         61,068
Net loss                             (142,390)      (178,530)      (509,116)      (169,806)      (209,484)
Dividend equivalent on Series
A Preferred Stock related to
beneficial conversion feature                -              -              -              -       (16,375)
Cumulative dividends for
Series A Preferred Stock               (1,576)        (1,309)        (3,309)        (3,655)        (2,489)
Net loss attributable to
common stockholders                  (143,966)      (179,839)      (512,425)      (173,461)      (228,348)
Loss per share:
Basic                                   (1.22)         (3.66)        (10.55)         (3.52)         (6.53)
Diluted                                 (1.22)         (3.66)        (10.55)         (3.52)         (6.53)
Weighted average number of
shares outstanding (1):
Basic                              118,001,162     49,144,429     48,572,979     49,257,696     34,971,461
Diluted                            118,001,162     49,144,429     48,572,979     49,257,696     34,971,461

Excluding in each case the 1,523,578 shares returned to the Company in the

(1) first quarter of 2020 in connection with the Appraisal Action, which were

treated as outstanding until they were returned to the Company.




                                                             As of December 31,
(in thousands)                        2021           2020           2019           2018           2017
Balance Sheet Data:
Cash and cash equivalents          $    20,775    $    68,221    $     6,198    $    36,206    $    39,000
Accounts receivable, net of
allowance for doubtful accounts        184,102        206,868        261,400        270,812        229,704
Working capital                      (220,002)      (131,446)      (147,056)      (123,502)       (68,634)
Total Assets                         1,037,023      1,157,779      1,258,324      1,627,823      1,717,232
Long­term debt, net of current
maturities                           1,104,399      1,498,004      1,398,385      1,306,423      1,276,094
Total liabilities                    1,703,795      2,084,311      2,001,365      1,869,082      1,769,029
Total stockholders' deficit          (666,772)      (926,532)      (743,041)      (241,259)       (51,797)

Potential Future Transactions



We may, from time to time explore and evaluate possible strategic transactions,
which may include joint ventures, as well as business combinations or the
acquisition or disposition of assets. In order to pursue certain of these
opportunities, additional funds will likely be required. Subject to applicable
contractual restrictions, to obtain such financing, we may seek to use cash on
hand, borrowings under our revolving credit facilities, or we may seek to raise
additional debt or equity financing through private placements or through
registered "at-the-market" or underwritten offerings. There can be no assurance
that we will enter into additional strategic transactions or alliances, nor do
we know if we will be able to obtain the necessary financing for transactions
that require additional funds on favorable terms, if at all. In addition,
pursuant to the Registration Rights Agreement that we entered into in connection
with the closing of the Novitex Business Combination, certain of our
stockholders have the right to demand underwritten offerings of our Common
Stock. We may from time to time in the future explore, with certain of those
stockholders the possibility of an underwritten public offering of our Common
Stock held by those stockholders. There can be no assurance as to whether or
when an offering may be commenced or completed, or as to the actual size or
terms of the offering.

Critical Accounting Policies and Estimates



The preparation of financial statements requires the use of judgments and
estimates. Our critical accounting policies are described below to provide a
better understanding of how we develop our assumptions and judgments about
future events and related estimations and how they can impact our financial
statements. A critical accounting estimate is one that requires subjective or
complex estimates and assessments, and is fundamental to our results of
operations. We base our estimates on historical experience and on various other
assumptions we believe to be reasonable according to the current facts and
circumstances, the results of which form the basis for making judgments about
the carrying values of assets and liabilities that are not readily apparent from
other sources. We believe the current assumptions, judgments and estimates used
to determine amounts reflected in our consolidated financial statements are

appropriate; however,

                                       60

  Table of Contents

actual results may differ under different conditions. This discussion and analysis should be read in conjunction with our consolidated financial statements and related notes included in this document.

Goodwill and other intangible assets: Goodwill and other intangible assets are
initially recorded at their fair values. Goodwill represents the excess of the
purchase price of acquisitions over the fair value of the net assets acquired.
Our goodwill at December 31, 2021 and 2020 was $358.3 million and
$359.8 million, respectively. Goodwill and other intangible assets not subject
to amortization are tested for impairment annually or more frequently if events
or changes in circumstances indicate that the asset might be impaired.
Intangible assets with finite useful lives are amortized either on a
straight-line basis over the asset's estimated useful life or on a basis that
reflects the pattern in which the economic benefits of the intangible assets are
realized.

Impairment of goodwill, long-lived and other intangible assets: Long-lived
assets, such as property and equipment and finite-lived intangible assets are
evaluated for impairment whenever events or changes in circumstances indicate
that their carrying value may not be recoverable. Recoverability is measured by
a comparison of their carrying amount to the estimated undiscounted cash flows
to be generated by those assets. If the undiscounted cash flows are less than
the carrying amount, we record impairment losses for the excess of the carrying
value over the estimated fair value. Fair value is determined, in part, by the
estimated cash flows to be generated by those assets. Our cash flow estimates
are based upon, among other things, historical results adjusted to reflect our
best estimate of future market rates, and operating performance. Development of
future cash flows also requires us to make assumptions and to apply judgment,
including timing of future expected cash flows, using the appropriate discount
rates, and determining salvage values. The estimate of fair value represents our
best estimates of these factors, and is subject to variability. Assets are
generally grouped at the lowest level of identifiable cash flows, which is the
reporting unit level for us. Changes to our key assumptions related to future
performance and other economic factors could adversely affect our impairment
valuation.

We conduct our annual goodwill impairment tests on October 1st of each year, or
more frequently if indicators of impairment exist. When performing the annual
impairment test, we have the option of performing a qualitative or quantitative
assessment to determine if an impairment has occurred. If a qualitative
assessment indicates that it is more likely than not that the fair value of a
reporting unit is less than its carrying amount, we would be required to perform
a quantitative impairment test for goodwill. A quantitative test requires
comparison of fair value of the reporting unit to its carrying value, including
goodwill. We use a combination of the Guideline Public Company Method of the
Market Approach and the Discounted Cash Flow Method of the Income Approach to
determine the reporting unit fair value. For the Guideline Public Company
Method, our annual impairment test utilizes valuation multiples of publicly
traded peer companies. For the Discounted Cash Flow Method, our annual
impairment test utilizes discounted cash flow projections using market
participant weighted average cost of capital calculation. If the fair value of
goodwill at the reporting unit level is less than its carrying value, an
impairment loss is recorded for the amount by which a reporting unit's carrying
amount exceeds its fair value, limited to the total amount of goodwill allocated
to that reporting unit.

We conducted our annual goodwill impairment tests for year 2021 and 2020 on October 1, 2021 and 2020, respectively, and concluded that there was no impairment in our goodwill and other intangible assets during these years.



Application of the goodwill impairment test requires judgment, including the
identification of reporting units, allocation of assets and liabilities to
reporting units, and determination of fair value. The determination of reporting
unit fair value is sensitive to the amount of Revenue and EBITDA generated by
us, as well as the Revenue and EBITDA market multiples used in the calculation.
Additionally, the fair value is sensitive to changes in the valuation
assumptions such as expected income tax rate, risk-free rate, asset beta, and
various risk premiums. Unanticipated changes, including immaterial revisions, to
these assumptions could result in a provision for impairment in a future period.
Given the nature of these evaluations and their application to specific assets
and time frames, it is not possible to reasonably quantify the impact of changes
in these assumptions.

In the process of reconciling the fair values of the Company's reporting units
to its overall market capitalization, the Company used a combination of both
quantitative and qualitative considerations, arriving at the implied control
premium of (9.1)%. The implied control premium was computed using the Company's
closing stock price as of October 1, 2021.

                                       61

Table of Contents



Revenue: We account for revenue in accordance with ASC 606. A performance
obligation is a promise in a contract to transfer a distinct good or service to
the customer, and is the unit of account in ASC 606. Revenue is measured as the
amount of consideration we expect to receive in exchange for transferring goods
or providing services. The contract transaction price is allocated to each
distinct performance obligation and recognized as revenue when, or as, the
performance obligation is satisfied. All of our material sources of revenue are
derived from contracts with customers, primarily relating to the provision of
business and transaction processing services within each of our segments. We do
not have any significant extended payment terms, as payment is received shortly
after goods are delivered or services are provided. Refer to Note 2-Basis of
Presentation and Summary of Significant Accounting Policies for additional
information regarding our revenue recognition policy.

Income Taxes: We account for income taxes by using the asset and liability method. We account for income taxes regarding uncertain tax positions and recognize interest and penalties related to uncertain tax positions in income tax benefit/(expense) in the consolidated statements of operations.



The Tax Cuts and Jobs Act ("TCJA") was signed by the President of the United
States and enacted into law on December 22, 2017. The TCJA significantly changes
U.S. tax law by reducing the U.S. corporate income tax rate to 21% from 35%,
adopting a territorial tax regime, creating new taxes on certain foreign sourced
earnings and imposing a one-time transition tax on the undistributed earnings of
certain non-U.S. subsidiaries.

Deferred income taxes are recognized on the tax consequences of temporary
differences by applying enacted statutory tax rates applicable in future years
to differences between the financial statement carrying amounts and the tax
bases of existing assets and liabilities, as determined under tax laws and
rates. A valuation allowance is provided when it is more likely than not that
all or some portion of the deferred tax assets will not be realized. Due to
numerous ownership changes, we are subject to limitations on existing net
operating losses under Section 382 of the Internal Revenue Code. In the event we
determine that we would be able to realize deferred tax assets that have
valuation allowances established, an adjustment to the net deferred tax assets
would be recognized as a component of income tax expense through continuing
operations.

We engage in transactions (such as acquisitions) in which the tax consequences
may be subject to uncertainty and examination by the varying taxing authorities.
Significant judgment is required by us in assessing and estimating the tax
consequences of these transactions. While our tax returns are prepared and based
on our interpretation of tax laws and regulations, in the normal course of
business the tax returns are subject to examination by the various taxing
authorities. Such examinations may result in future assessments of additional
tax, interest and penalties. For purposes of our income tax provision, a tax
benefit is not recognized if the tax position is not more likely than not to be
sustained based solely on its technical merits. Considerable judgment is
involved in determining which tax positions are more likely than not to be
sustained.

Business Combinations: We allocate the total cost of an acquisition to the
underlying assets based on their respective estimated fair values. Determination
of fair values involves significant estimates and assumptions about highly
subjective variables, including future cash flows, discount rates, and asset
lives. The estimates of the fair values of assets and liabilities acquired are
based upon assumptions believed to be reasonable and, when appropriate, include
assistance from independent third-party valuation firms.

Because we are primarily a services business, our acquisitions typically result
in significant amounts of goodwill and other intangible assets. Fair value
estimates and calculations for these acquisitions will affect the amount of
amortization expense, or possible impairment related charges recognized in
future periods. We base our fair value estimates on assumptions we believe are
reasonable, but recognize that the assumptions are inherently uncertain.

Recently Adopted and Recently Issued Accounting Pronouncements

See Note 2 to the consolidated financial statements.



                                       62

Table of Contents

Internal Controls and Procedures



As a publicly traded company, we are required to comply with the SEC's rules
implementing Section 302 and 404 of the Sarbanes-Oxley Act, which require
management to certify financial and other information in our quarterly and
annual reports and provide an annual management report on the effectiveness of
controls over financial reporting. For management's assessment of internal
control over financial reporting required by Item 308(a) of Regulation S-K for
the year ended December 31, 2021 see Part II-Item 9A - Controls and Procedures
for management's report on the effectiveness of internal controls.

© Edgar Online, source Glimpses